rs142331975
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_024422.6(DSC2):c.607C>T(p.Arg203Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R203H) has been classified as Pathogenic.
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.607C>T | p.Arg203Cys | missense_variant | 5/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.607C>T | p.Arg203Cys | missense_variant | 5/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.178C>T | p.Arg60Cys | missense_variant | 5/16 | NP_001393435.1 | ||
DSC2 | NM_001406507.1 | c.178C>T | p.Arg60Cys | missense_variant | 5/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.607C>T | p.Arg203Cys | missense_variant | 5/16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081.8 | c.607C>T | p.Arg203Cys | missense_variant | 5/17 | 1 | ENSP00000251081.6 | |||
DSC2 | ENST00000648081.1 | c.178C>T | p.Arg60Cys | missense_variant | 6/17 | ENSP00000497441.1 | ||||
DSC2 | ENST00000682357.1 | c.178C>T | p.Arg60Cys | missense_variant | 5/16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251392Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135862
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461578Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727098
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 11 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 203 of the DSC2 protein (p.Arg203Cys). This variant is present in population databases (rs142331975, gnomAD 0.0009%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 21062920, 23514727, 25825460). ClinVar contains an entry for this variant (Variation ID: 72377). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DSC2 protein function. Experimental studies have shown that this missense change affects DSC2 function (PMID: 21062920). This variant disrupts the p.Arg203 amino acid residue in DSC2. Other variant(s) that disrupt this residue have been observed in individuals with DSC2-related conditions (PMID: 21636032), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Mar 17, 2020 | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Nov 15, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 22, 2015 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg203Cys variant in DSC2 has been reported in 1 heterozygous Caucasian individual with A RVC (Gehmlich 2011) and in 1 Japanese individual with ARVC who carried 2 additio nal DSC2 variants (Ohno 2013). Testing of relatives of the proband reported by O hno 2013 detected the Arg203Cys variant in 1 of 2 relatives with a possible diag nosis of ARVC. This variant has been previously identified by our laboratory in two homozygous adults of Middle Eastern descent with ARVC and biventricular DCM, one of whom had additional minimal features of recessive ARVC. The variant was absent from large population studies but it should be noted that these did not s urvey a large enough number of Middle Eastern individuals to rule out that it is common in this population. Cell culture studies do suggest that the variant aff ects protein function (Gehmlich 2011) although these types of studies may not ac curately reflect biological function. Computational predictions also support tha t the variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Arg203Cys variant is unce rtain. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2022 | The c.607C>T (p.R203C) alteration is located in exon 5 (coding exon 5) of the DSC2 gene. This alteration results from a C to T substitution at nucleotide position 607, causing the arginine (R) at amino acid position 203 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at